Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 1.21 | 1.25 | 1.23 | 1.32 | 1.45 |
| Reported EPS($) | 1.41 | 1.28 | 1.27 | 1.36 | NA |
| GAAP($) | 1.23 | 1.23 | 1.12 | 1.12 | NA |
| Mar 2013* | Jun 2013* | Jun 2013** | Jun 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 1.45 | 1.56 | 5.63 | 6.59 |
| Number of Analysts | 15 | 15 | 15 | 15 |
| Low Estimate ($) | 1.36 | 1.48 | 5.49 | 6.20 |
| High Estimate ($) | 1.54 | 1.64 | 5.73 | 6.75 |
| Mar 2013* | Jun 2013* | Jun 2013** | Jun 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 1.45 | 1.56 | 5.63 | 6.59 |
| 30 Days Ago ($) | 1.45 | 1.56 | 5.63 | 6.58 |
| 90 Days Ago ($) | 1.43 | 1.51 | 5.54 | 6.35 |
| Jun 2013* | Jun 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| PRGO | 24.06% | 13.79% | 13.36% | 20.89 | 1.39 | |
